Mutations in BRCA1 and BRCA2 (hereafter referred to as BRCA1/2), the most important genetic susceptibility markers, account for up to 15% and 30% of the familial recurrence risk (FRR) of overall and high-risk breast cancers15. Here, BRCA1 is linked to neoplasm.